Skip to content

Hypertension Approaches in the Elderly: a Lifestyle Study

Combined Training and Health Education for Hypertensive Elders: a Multicenter Randomized Clinical Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03264443
Acronym
HAEL
Enrollment
184
Registered
2017-08-29
Start date
2017-09-01
Completion date
2020-08-31
Last updated
2020-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Keywords

physical activity, exercise, aging, older

Brief summary

Two-center randomized, parallel, controlled trial which will compare a pragmatic combined training program with a health education program in 184 older adults with hypertension. This study will last 12 weeks with assessments conducted at baseline, previously to the group allocation, and after interventions. There is a set of secondary outcomes which show clinical importance to the elderly population and are possibly influenced by the tested intervention.

Detailed description

The present protocol describes a randomized controlled trial that aims to evaluate blood pressure effects of a pragmatic combined training program, with low equipment needs, in comparison with a health education program. The sample is composed by 184 older adults, divided in two implementation centers. Randomization ratio will be 1:1 and interventions will last 12 weeks, with three weekly sessions for the exercise arm and one to the health education arm. In order to analyze the effects of interventions in a comprehensive way, a range of variables related to ambulatory blood pressure (primary outcome), physical fitness, vascular and autonomous function, together with emotional and cognitive aspects will be evaluated in a pre-post fashion. The study's hypothesis, as well as the sample size calculation and analysis plan, is based on a superiority expectation for the exercise program in comparison with the health education program, especially for the blood pressure control, functional capacity and quality of life. The present study was designed and will be conducted by a multidisciplinary staff and follows ethical and methodological recommendations for clinical trials. It is expected that this multicenter randomized trial will provide scientific evidences with a high applicability to the non-pharmacological management of hypertension in the elderly.

Interventions

BEHAVIORALHealth education

Weekly group lectures (1h each) giving information on patient's best practices to manage hypertension.

Combined training (aerobic and strength exercises), in moderate intensities (perceived exertion controlled) performed 3x/week (1h) duration with a education component (10') based on the contents of the health intervention.

Sponsors

Federal University of Pelotas
CollaboratorOTHER
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Hypertension diagnosis (through ambulatory blood pressure monitoring or medication use) * Verified ability to exercise * Unaltered pharmacological plan within previous 4 weeks * Willingness to participate in any of interventions

Exclusion criteria

* Inability or refusal to give written consent * Myocardial infarction, revascularization proceedings, deep vein thrombosis * Severe cardiovascular disease (class III or IV heart failure, uncontrolled arrhythmia, unstable angina, or use of implantable defibrillator * Chronic pulmonary disease which requires the use of oxygen or steroidal therapy * Incidence of cardiovascular event, hospitalization or other severe health-related event during the experimental period * High alcohol consumption (over 14 doses per week) * Renal disease needing dialysis * Language, cognitive or hearing problems * Plans of moving to another city during the study * Living together with another person enrolled in the study * Osteoarticular or muscular injuries or another health conditions which generate inability to carry on the interventions * Progressive neurological disorders (Parkinson, multiple sclerosis, etc.) * Cancer treatment in the past 2 years * A medical report indicating exercise counterindication based cardiopulmonary exercise testing

Design outcomes

Primary

MeasureTime frameDescription
Ambulatory Blood PressureChange from baseline 24-hour systolic blood pressure at 12 weeks24h ambulatory blood pressure measured through automatic oscillometric device

Secondary

MeasureTime frameDescription
Lower limbs functional capacityChange from baseline SPPB score at 12 weeksBy using the Short Physical Performance Battery (SPPB), lower-limb mobility will be assess in the following sequence: static standing balance, walking speed and indirect muscle strength
Cardiorespiratory fitnessChange from baseline VO2peak at 12 weeksOxygen consumption at peak (VO2peak) as assessed by maximal cardiopulmonary exercise testing
Geriatric Depression SymptomsChange from baseline GDS-15 score at 12 weeks15-item depression symptoms scale (GDS-15)
Walking distanceChange from baseline walking distance at 12 weeksLongest distance walked as assessed by the six-minute walk test
Autonomic functionChange from baseline beat-to-beat blood pressure variability at 12 weeksBasal and during Stroop Color-Word Conflict Test beat-to-beat blood pressure variability
Endothelial function, early adaptationChange from baseline FMD at 6 weeksFlow-mediated dilatation (FMD) assessed through high resolution ultrasonography
Endothelial functionChange from baseline FMD at 12 weeksFlow-mediated dilatation (FMD) assessed through high resolution ultrasonography
Quality of life (QoL)Change from baseline QoL score at 12 weeksWorld Health Organization Quality of Life questionnaire

Countries

Brazil

Contacts

Primary ContactDaniel Umpierre, PhD
daniel.umpierre@gmail.com+555133596332
Backup ContactLucas P Santos, MSc
lucaspsantos87@gmail.com+555133596332

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026